Aerovate Therapeutics, Inc.

Calculating rank

USPTO Granted Patents = 6

Forward Citations = 4

Loading Chart...

3 inventors (with patents filed for the assignee):

Ben Dake (6 out of 6 patents)

Ralph Niven (6 out of 6 patents)

Andrew D Levin (3 out of 24 patents)

6 patents: Sort by Forward Citations

1. 11813263 - Inhalable imatinib formulations, manufacture, and uses thereof (2023-11-14),

2. 11806349 - Inhalable imatinib formulations, manufacture, and uses thereof (2023-11-07),

3. 11464776 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-10-11),

4. 11413289 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-08-16),

5. 11298355 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-04-12),

6. 11229650 - Inhalable imatinib formulations, manufacture, and uses thereof (2022-01-25),

Company Overview

Aerovate Therapeutics, Inc. is a biotechnology company focused on discovering and developing transformative therapies for respiratory diseases. With a strong pipeline of innovative drug candidates, Aerovate is dedicated to improving the lives of patients suffering from conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary fibrosis. Through cutting-edge research and collaboration with industry leaders, Aerovate is poised to make a significant impact in the field of respiratory medicine.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#268 in Boston, MA

#2,548 in Massachusetts

#45,030 in US

Boston, MA, United States of America